Skip to content
August 23, 2025

My Blog

  • Sample Page

Annual & Ongoing FDA Compliance Services – XPRO AMERICA


Posted on August 22, 2025 | Posted on admin | Leave a Comment on Annual & Ongoing FDA Compliance Services – XPRO AMERICA

For companies regulated by the U.S. Food and Drug Administration (FDA), compliance is not a one-time process but an ongoing responsibility. Each year, manufacturers, distributors, importers, and other regulated entities…

| Tagged FDA annual compliance, FDA annual reporting, FDA compliance consulting, FDA compliance monitoring, FDA compliance partner, FDA consulting company, FDA device listing update, FDA device regulation, fda establishment registration, FDA global compliance, FDA listing management, FDA ongoing compliance, fda registration renewal, FDA registration services, FDA regulation monitoring, FDA regulatory services, FDA regulatory updates, FDA renewal services, XPRO America compliance

510(k) Premarket Notification & Clearance Support – XPRO AMERICA


Posted on August 22, 2025 | Posted on admin | Leave a Comment on 510(k) Premarket Notification & Clearance Support – XPRO AMERICA

The 510(k) Premarket Notification is the primary FDA submission pathway for most Class II medical devices. It demonstrates that a new device is substantially equivalent to a legally marketed predicate…

| Tagged 510(k) FDA submission, 510(k) regulatory consulting, 510(k) testing support, Class II device clearance, FDA clearance guidance, FDA compliance management, FDA device approval, FDA device listing, FDA dossier preparation, fda establishment registration, FDA labeling compliance, FDA premarket notification, FDA reviewer communication, FDA risk assessment, FDA substantial equivalence, FDA technical file review, medical device regulatory support, medical device submission, XPRO America 510(k) services

XPRO America – US FDA Drug Establishment Registration (21 CFR Part 207)


Posted on August 21, 2025 | Posted on admin | Leave a Comment on XPRO America – US FDA Drug Establishment Registration (21 CFR Part 207)

The US FDA Drug Establishment Registration is a mandatory requirement under 21 CFR Part 207 for all facilities engaged in the manufacturing, repacking, relabeling, or distribution of human and veterinary…

| Tagged 21 CFR Part 207 compliance, FDA biennial renewal registration, FDA cGMP registration support, FDA drug distributor registration, FDA drug establishment registration, FDA drug facility registration, FDA drug listing services, FDA drug manufacturer registration, FDA drug product listing consultant, FDA drug regulatory compliance, FDA ESG submission support, FDA FEI number registration, FDA human drug registration, FDA pharmaceutical facility registration, FDA registration services pharmaceuticals, FDA relabeler registration, FDA repacker registration, FDA SPL drug listing, FDA veterinary drug registration

XPRO America – FDA Product Recall & Enforcement Guidance Services


Posted on August 21, 2025 | Posted on admin | Leave a Comment on XPRO America – FDA Product Recall & Enforcement Guidance Services

In the highly regulated pharmaceutical and healthcare industry, compliance with the U.S. Food and Drug Administration (FDA) is not optional it is a business necessity. When drug products are found…

| Tagged FDA adulterated drug recall, FDA compliance consulting, FDA corrective action planning, FDA drug recall assistance, FDA enforcement actions, FDA enforcement guidance, FDA enforcement support, FDA liaison services, FDA product misbranding recall, FDA product recall guidance, FDA recall classification, FDA recall communication, FDA recall compliance, FDA recall documentation, FDA recall process consulting, FDA recall services, FDA recall strategy, FDA regulatory enforcement, FDA voluntary recall support

XPRO America – FDA Post-Market Reporting & Pharmacovigilance Support


Posted on August 21, 2025 | Posted on admin | Leave a Comment on XPRO America – FDA Post-Market Reporting & Pharmacovigilance Support

Pharmaceutical companies must ensure the safety and effectiveness of their products even after FDA approval and U.S. market entry. This ongoing responsibility is managed through post-market reporting and pharmacovigilance programs,…

| Tagged FAERS submission support, FDA adverse event compliance, FDA adverse event reporting, FDA drug compliance services, FDA drug safety compliance, FDA drug safety monitoring, FDA MedWatch reporting service, FDA pharmacovigilance, FDA pharmacovigilance audit, FDA post-market reporting, FDA PSUR submission, FDA reporting outsourcing, FDA risk management REMS, FDA safety reporting system, MedWatch FDA compliance, pharmacovigilance outsourcing USA, post-market drug surveillance, post-market FDA support, XPRO America pharmacovigilance

OTC Drug Monograph Compliance & FDA Labeling Support – XPRO America


Posted on August 21, 2025 | Posted on admin | Leave a Comment on OTC Drug Monograph Compliance & FDA Labeling Support – XPRO America

Over-the-counter (OTC) drugs play a vital role in the U.S. healthcare market, allowing consumers to access safe and effective treatments without a prescription. To ensure public safety, the U.S. Food…

| Tagged CARES Act OTC drugs, FDA OTC compliance, FDA OTC drug consulting, FDA OTC drug regulations, FDA OTC drug review, FDA OTC labeling, FDA OTC labeling review, FDA OTC product approval, OTC drug compliance, OTC drug facts panel, OTC drug GMP compliance, OTC drug marketing compliance, OTC drug monograph FDA, OTC FDA regulation support, OTC formulation compliance, OTC labeling requirements, OTC monograph reform, OTC regulatory consulting, XPRO America OTC compliance

XPRO America – FDA Import Compliance & Customs Clearance Support


Posted on August 21, 2025 | Posted on admin | Leave a Comment on XPRO America – FDA Import Compliance & Customs Clearance Support

Importing Active Pharmaceutical Ingredients (APIs) and finished drug products into the United States requires strict compliance with U.S. Food and Drug Administration (FDA) and U.S. Customs & Border Protection (CBP)…

| Tagged API import FDA, CBP FDA clearance, drug import clearance, drug labeling compliance, FDA customs support, FDA drug compliance services, FDA drug registration, FDA import alert resolution, FDA import compliance, FDA import detention, FDA import documentation, FDA pharmaceutical customs, FDA Prior Notice filing, FDA shipment detention prevention, import API FDA registration, NDC drug listing, pharmaceutical customs clearance, US Agent FDA drugs, XPRO America import support

XPRO America – FDA Inspection & Audit Readiness Services for Compliance


Posted on August 21, 2025 | Posted on admin | Leave a Comment on XPRO America – FDA Inspection & Audit Readiness Services for Compliance

For FDA-regulated industries such as food, cosmetics, dietary supplements, and pharmaceuticals, preparing for an FDA inspection is essential to ensure uninterrupted market access. Inspections are designed to verify compliance with…

| Tagged FDA audit checklist, FDA audit corrective actions, FDA audit preparation, FDA audit readiness program, FDA audit response support, FDA audit services, FDA CAPA planning, FDA compliance audit, FDA compliance consulting, FDA documentation review, FDA Form 483 response, FDA inspection compliance, FDA inspection outsourcing, FDA inspection readiness, FDA inspection training, FDA mock inspection, FDA regulatory inspection prep, FDA warning letter support, XPRO America FDA audit

FDA Drug Listing & NDC Number Assignment (SPL Submissions) – XPRO America


Posted on August 21, 2025 | Posted on admin | Leave a Comment on FDA Drug Listing & NDC Number Assignment (SPL Submissions) – XPRO America

The US FDA Drug Listing process is a mandatory compliance requirement for all human and veterinary drug products marketed in the United States. Under 21 CFR Part 207, every registered…

| Tagged FDA drug distributor listing, FDA drug labeling compliance, FDA drug listing, FDA drug listing consultant, FDA drug product listing, FDA drug regulatory compliance, FDA drug relabeler listing, FDA drug repacker listing, FDA ESG drug listing, FDA human drug listing, FDA NDC assignment, FDA NDC code services, FDA NDC number, FDA package code assignment, FDA pharmaceutical product listing, FDA product code assignment, FDA SPL drug submission, FDA veterinary drug listing, National Drug Code registration

FDA Drug Labeling Compliance & SPL Submission Services – XPRO America


Posted on August 21, 2025 | Posted on admin | Leave a Comment on FDA Drug Labeling Compliance & SPL Submission Services – XPRO America

Accurate and compliant drug labeling is one of the most critical requirements for marketing human and veterinary drugs in the United States. Under 21 CFR Part 201, the U.S. Food…

| Tagged 21 CFR 201 compliance, drug claims compliance, drug labeling compliance services, drug package insert compliance, drug relabeling compliance, FDA drug facts panel, FDA drug label review, FDA drug labeling, FDA drug warnings compliance, FDA inactive ingredient database, FDA label claims verification, FDA label compliance consulting, FDA labeling requirements, inactive ingredient FDA check, pharmaceutical labeling compliance, SPL drug submissions, SPL formatting FDA, structured product labeling FDA, XPRO America drug labeling

Posts pagination

Previous 1 2 3 4 … 2,921 Next

Recent Posts

  • US FDA FCE & SID Registration – XPRO AMERICA
  • US FDA Compliance for Dietary Supplements & Nutraceuticals – XPRO AMERICA
  • US FDA GRAS & Food Additive Consultation – XPRO AMERICA
  • US FDA Importer Assistance for FSVP Compliance – XPRO AMERICA
  • FDA Inspection & Audit Readiness – XPRO AMERICA

Recent Comments

No comments to show.

Archives

  • August 2025
  • July 2024
  • October 2023
  • September 2023
  • July 2023

Categories

  • Uncategorized
About Us

Nam malesuada nulla nisi, ut faucibus magna congue nec. Ut libero tortor, tempus at auctor in, molestie at nisi. In enim ligula, consequat eu feugiat a.

Useful Links
  • Home
  • services
  • Reviews
  • About Us
Information
  • FAQ
  • Site Maps
  • Privacy Policy
  • Contact Us
Get In Touch
  • Via Carlo Montù 78
    22021 Bellagio CO, Italy
  • +11 6254 7855
  • support@example.com
Proudly powered by WordPress | Viral News WordPress Theme by TheMagnifico.